81 related articles for article (PubMed ID: 6383334)
1. Demonstration of lysozyme in primary ovarian tumors using the immunoperoxidase technique.
Cazzola P; Lo Re V; Matturri L; Tedeschi D
Basic Appl Histochem; 1984; 28(2):169-76. PubMed ID: 6383334
[TBL] [Abstract][Full Text] [Related]
2. Amylase in fallopian tube and serous ovarian neoplasms: immunohistochemical localization.
Bruns DE; Mills SE; Savory J
Arch Pathol Lab Med; 1982 Jan; 106(1):17-20. PubMed ID: 6172088
[TBL] [Abstract][Full Text] [Related]
3. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.
Devaney K; Goodman ZD; Ishak KG
Am J Surg Pathol; 1994 Nov; 18(11):1078-91. PubMed ID: 7943529
[TBL] [Abstract][Full Text] [Related]
4. Immunolocalization of alpha-amylase in ovarian mucinous tumours.
Griffin NR; Wells M
Int J Gynecol Pathol; 1990; 9(1):41-6. PubMed ID: 2294062
[TBL] [Abstract][Full Text] [Related]
5. Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Romanini C; Biagini G
Anticancer Res; 1996; 16(4A):2123-7. PubMed ID: 8712754
[TBL] [Abstract][Full Text] [Related]
6. [Histopathology of the ovarian tumors derived from the Müllerian (paramesonephric) epithelium and their differential diagnosis. I. Adenofibroma. Serous and mucinous cystadenomas and cystadenocarcinomas (author's transl)].
Jirásek JE
Cesk Gynekol; 1973 Nov; 38(9):705-8. PubMed ID: 4765179
[No Abstract] [Full Text] [Related]
7. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors.
Huang LW; Garrett AP; Bell DA; Welch WR; Berkowitz RS; Mok SC
Gynecol Oncol; 2000 Jun; 77(3):369-76. PubMed ID: 10831344
[TBL] [Abstract][Full Text] [Related]
8. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
[TBL] [Abstract][Full Text] [Related]
9. [Muramidase activity in the fluid content of ovarian cysts].
Kovanyi G; Holzner H
Wien Klin Wochenschr; 1970 May; 82(20):375-8. PubMed ID: 5524224
[No Abstract] [Full Text] [Related]
10. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
Liu MP; Lu ZT; Chen W
Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120
[TBL] [Abstract][Full Text] [Related]
11. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
[TBL] [Abstract][Full Text] [Related]
12. [A case of serous papillary cystadenocarcinoma of the ovary with hyperamylasemia].
Nakamura S; Hirabayashi N; Asai J
Gan No Rinsho; 1987 Apr; 33(4):428-33. PubMed ID: 2437341
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of DEK overexpression in serous ovarian tumors.
Han S; Xuan Y; Liu S; Zhang M; Jin D; Jin R; Lin Z
Pathol Int; 2009 Jul; 59(7):443-7. PubMed ID: 19563407
[TBL] [Abstract][Full Text] [Related]
14. Epithelial ovarian tumors in children: a retrospective analysis.
Morowitz M; Huff D; von Allmen D
J Pediatr Surg; 2003 Mar; 38(3):331-5; discussion 331-5. PubMed ID: 12632344
[TBL] [Abstract][Full Text] [Related]
15. Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas.
Kauppila S; Saarela J; Stenbäck F; Risteli J; Kauppila A; Risteli L
Am J Pathol; 1996 Feb; 148(2):539-48. PubMed ID: 8579116
[TBL] [Abstract][Full Text] [Related]
16. In situ human telomerase reverse transcriptase expression pattern in normal and neoplastic ovarian tissues.
Baykal A; Thompson JA; Xu XC; Hahn WC; Deavers MT; Malpica A; Gershenson DM; Silva EG; Liu J
Oncol Rep; 2004 Feb; 11(2):297-302. PubMed ID: 14719058
[TBL] [Abstract][Full Text] [Related]
17. Numerical abnormalities of chromosomes 1, 11, 17, and X are associated with stromal invasion in serous and mucinous epithelial ovarian tumours.
Evans MF; McDicken IW; Herrington CS
J Pathol; 1999 Sep; 189(1):53-9. PubMed ID: 10451488
[TBL] [Abstract][Full Text] [Related]
18. Management of ovarian carcinoma: a review of 14 years' experience at Beth Israel Hospital.
Blinick G; Kabakow B; Antopol W; Wallach RC
Mt Sinai J Med; 1972; 39(5):447-57. PubMed ID: 4628079
[No Abstract] [Full Text] [Related]
19. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
20. Mucinous tumors of the ovary with argyrophil cells. An immunohistochemical analysis.
Aguirre P; Scully RE; Dayal Y; DeLellis RA
Am J Surg Pathol; 1984 May; 8(5):345-56. PubMed ID: 6203413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
